Thierry Burnouf on Platelet-Derived Extracellular Vesicles and Their Role in Neurogenesis
Thierry Burnouf, Vice-Dean, Distinguished Professor, Biomedical Engineering at Taipei Medical University, shared on LinkedIn:
”New paper published in Biomaterials: “Platelet concentrate–derived extracellular vesicles promote adult hippocampal neurogenesis” by Ariunjargal Nyam-Erdene, Nhi Thao Ngoc Le, Ouada N.,Emilie Faivre, liling delila, Ming-Li Chou, Joshua Lowe, Kadiombo Bantubungi-Blum, Luc Buee, Luc Buee, Tara Walker, David Blum, and Thierry Burnouf.
DOI: 10.1016/j.biomaterials.2025.123838
This work is the result of a collaboration between Taipei Medical University, University of Lille-, and UQ Queensland Brain Institute.
Key messages of the paper:
(1) Demonstrates that the platelet concentrate–derived secretome enhances neurogenesis in the adult brain, which is a critical step toward clinical translation.
(2) Uses clinically-approved platelet concentrates as starting material, showing a realistic pathway for GMP-compatible, scalable production of the platelet secretome.
(3) Shows how expired or surplus platelet units from blood establishments can be transformed into high-value biotherapies, instead of being discarded.
(4) Combines expertise from TMU (platelet-derived products), ULille (neurodegenerative diseases), and QBI (adult neurogenesis and brain repair), exemplifying a model of translational, international collaboration.”
Read the full article here.
Article: Platelet concentrate-derived extracellular vesicles promote adult hippocampal neurogenesis
Authors: Ariunjargal NyamErdene, Nhi Thao Ngoc Le, Ouada Nebie, Emilie Faivre, Liling Delila, Ming-Li Chou, Joshua R. Lowe, Kadiombo Bantubungi, Luc Buée, Tara L. Walker, David Blum, Thierry Burnouf
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 3, 2026, 04:09Pedro Perez: Are We Entering a New Era in the Treatment of Intermediate-High-Risk PE?
-
Sep 3, 2026, 04:01Marianne Yee: Supporting Families and Transformative Therapies in Sickle Cell Disease
-
Sep 3, 2026, 03:51Strengthening Bleeding Disorders Care in New Zealand – WFH
-
Sep 3, 2026, 03:42Nathan Connell: FDA Approves Rusfertide for Polycythemia Vera
-
Sep 3, 2026, 03:28Katrina Snow: Learning More About Sickle Cell Disease This September
-
Sep 3, 2026, 01:19Himanshu Aggarwal: 1 mg/kg/d Thalidomide Non-Inferior to Standard Dose in Transfusion-Dependent Thalassemia
-
Sep 3, 2026, 01:03SHOT Urges Safe Component Matching While NHSBT Appeals for Black Donors
-
Sep 3, 2026, 00:52David Wallace: FDA Approves MIMRYLO to Target Iron Regulation and Reduce Phlebotomy Burden
-
Sep 3, 2026, 00:44Same goal, Different molecular strategy – Which FVIIIa Mimetic Gets There How? – RPTH Journal